Cardiology - Hypertension
A 58-year-old man with a five-year history of essential hypertension was started on an angiotensin-converting enzyme (ACE) inhibitor. Twelve days later, he presented to the emergency department with acute swelling of the lips and tongue without urticaria or respiratory compromise. ACE inhibitor-induced angioedema was diagnosed, and the drug was discontinued.
At the time of his original hypertension diagnosis, his blood pressure had averaged 168/98 mmHg, and electrocardiography (ECG) demonstrated left ventricular hypertrophy (LVH) by voltage criteria. He had no history of heart failure, coronary artery disease or chronic kidney disease. Following discontinuation of the ACE inhibitor, continued antihypertensive therapy was required.
After complete resolution of the angioedema, the treating team considered whether an angiotensin receptor blocker (ARB) could be used. Six weeks after ACE inhibitor discontinuation, losartan was initiated at a low dose, with counselling regarding the small residual risk of recurrent angioedema and instructions to seek urgent medical attention if facial, lip or tongue swelling occurred.
The patient tolerated losartan without recurrence of angioedema. The dose was subsequently titrated, with blood pressure progressively controlled to target. At follow-up, repeat ECG demonstrated regression of LVH.
0 Likes
0 Comments
Stay at the forefront of hypertension management by joining our HTN Updates Forum. Access expert-curated infographics, real-world case reports, engaging eCMEs, and insightful videos that translate the scientific evidence into practical clinical knowledge. Designed exclusively for healthcare professionals, the forum delivers the latest evidence, guideline updates, and practical clinical insights to support confident, evidence-based treatment decisions. Follow the forum to stay informed with emerging research and expert perspectives in hypertension care.
© 2026 i-rhythm, All Rights Reserved. MSN i-Rhythm does not provide medical advice, diagnosis or treatment.
For unrestricted access to content and a seamless experience,
Complete your profile to help us deliver a more personalized experience.